Literature DB >> 28617945

microRNA cluster 106a~363 is involved in T helper 17 cell differentiation.

Marc Kästle1, Sabine Bartel1,2, Kerstin Geillinger-Kästle3, Martin Irmler4, Johannes Beckers4,5,6, Bernhard Ryffel7, Oliver Eickelberg1, Susanne Krauss-Etschmann1,2,8.   

Abstract

T-helper cell type 17 (Th17) mediated inflammation is associated with various diseases including autoimmune encephalitis, inflammatory bowel disease and lung diseases such as chronic obstructive pulmonary disease and asthma. Differentiation into distinct T helper subtypes needs to be tightly regulated to ensure an immunological balance. As microRNAs (miRNAs) are critical regulators of signalling pathways, we aimed to identify specific miRNAs implicated in controlling Th17 differentiation. We were able to create a regulatory network model of murine T helper cell differentiation by combining Affymetrix mRNA and miRNA arrays and in silico analysis. In this model, the miR-212~132 and miR-182~183 clusters were significantly up-regulated upon Th17 differentiation, whereas the entire miR-106~363 cluster was down-regulated and predicted to target well-known Th17 cell differentiation pathways. In vitro transfection of miR-18b, miR-106a and miR-363-3p into primary murine Cd4+ lymphocytes decreased expression of retinoid-related orphan receptor c (Rorc), Rora, Il17a and Il17f, and abolished secretion of Th17-mediated interleukin-17a (Il17a). Moreover, we demonstrated target site-specific regulation of the Th17 transcription factors Rora and nuclear factor of activated T cells (Nfat) 5 by miR-18b, miR-106a and miR-363-3p through luciferase reporter assays. Here, we provide evidence that miRNAs are involved in controlling the differentiation and function of T helper cells, offering useful tools to study and modify Th17-mediated inflammation.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  T helper cell differentiation; T helper type 17; miR-106a; miR-18b; miR-363a-3p; microRNA; nuclear factor of activated T cells 5; retinoid-related orphan receptor α; retinoid-related orphan receptor γt

Mesh:

Substances:

Year:  2017        PMID: 28617945      PMCID: PMC5629441          DOI: 10.1111/imm.12775

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells.

Authors:  Yong Huang; YingFeng Lei; Hai Zhang; LiChao Hou; Mingjie Zhang; Andrew I Dayton
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.

Authors:  Endong Zhu; Xi Wang; Bin Zheng; Qian Wang; Jianlei Hao; Siming Chen; Qiang Zhao; Liqing Zhao; Zhenzhou Wu; Zhinan Yin
Journal:  J Immunol       Date:  2014-05-19       Impact factor: 5.422

3.  Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.

Authors:  Ming Zhao; Dingya Sun; Yangtai Guan; Zhihong Wang; Daoqian Sang; Mingdong Liu; Yingyan Pu; Xue Fang; Dan Wang; Aijun Huang; Xiaoying Bi; Li Cao; Cheng He
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

4.  Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Authors:  Timothy J Harris; Joseph F Grosso; Hung-Rong Yen; Hong Xin; Marcin Kortylewski; Emilia Albesiano; Edward L Hipkiss; Derese Getnet; Monica V Goldberg; Charles H Maris; Franck Housseau; Hua Yu; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

5.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.

Authors:  Weitao Huang; Li Na; Paul L Fidel; Paul Schwarzenberger
Journal:  J Infect Dis       Date:  2004-06-22       Impact factor: 5.226

6.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

Review 7.  Immunology of asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Nat Rev Immunol       Date:  2008-02-15       Impact factor: 53.106

8.  Evaluating the microRNA targeting sites by luciferase reporter gene assay.

Authors:  Yi Jin; Zujian Chen; Xiqiang Liu; Xiaofeng Zhou
Journal:  Methods Mol Biol       Date:  2013

9.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.

Authors:  Marc Veldhoen; Keiji Hirota; Astrid M Westendorf; Jan Buer; Laure Dumoutier; Jean-Christophe Renauld; Brigitta Stockinger
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

10.  Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.

Authors:  Jens Ingwersen; Til Menge; Britta Wingerath; Derya Kaya; Jonas Graf; Tim Prozorovski; Andreas Keller; Christina Backes; Markus Beier; Matthias Scheffler; Thomas Dehmel; Bernd C Kieseier; Hans-Peter Hartung; Patrick Küry; Orhan Aktas
Journal:  Ann Clin Transl Neurol       Date:  2014-12-05       Impact factor: 4.511

View more
  17 in total

1.  Machine Learning Approach for Predicting Past Environmental Exposures From Molecular Profiling of Post-Exposure Human Serum Samples.

Authors:  Atif Khan; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps; Philip K Hopke; Mark J Utell; Pamela L Krahl; Timothy M Mallon; Juilee Thakar
Journal:  J Occup Environ Med       Date:  2019-12       Impact factor: 2.162

Review 2.  The evolving role of TonEBP as an immunometabolic stress protein.

Authors:  Soo Youn Choi; Whaseon Lee-Kwon; Hyug Moo Kwon
Journal:  Nat Rev Nephrol       Date:  2020-03-10       Impact factor: 28.314

3.  The YAP/HIF-1α/miR-182/EGR2 axis is implicated in asthma severity through the control of Th17 cell differentiation.

Authors:  Jing Zhou; Ning Zhang; Wei Zhang; Caiju Lu; Fei Xu
Journal:  Cell Biosci       Date:  2021-05-12       Impact factor: 7.133

Review 4.  MicroRNA Regulation of Host Immune Responses following Fungal Exposure.

Authors:  Tara L Croston; Angela R Lemons; Donald H Beezhold; Brett J Green
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

Review 5.  Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease.

Authors:  Timothy Sadlon; Cheryl Y Brown; Veronika Bandara; Christopher M Hope; John E Schjenken; Stephen M Pederson; James Breen; Alistair Forrest; Marc Beyer; Sarah Robertson; Simon C Barry
Journal:  Clin Transl Immunology       Date:  2018-02-27

Review 6.  Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases.

Authors:  Jae-Ung Lee; Li-Kyung Kim; Je-Min Choi
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

7.  Immunological Molecular Responses of Human Retinal Pigment Epithelial Cells to Infection With Toxoplasma gondii.

Authors:  Shervi Lie; Elise Rochet; Erik Segerdell; Yuefang Ma; Liam M Ashander; Audra M A Shadforth; Timothy A Blenkinsop; Michael Z Michael; Binoy Appukuttan; Beth Wilmot; Justine R Smith
Journal:  Front Immunol       Date:  2019-05-01       Impact factor: 7.561

8.  MicroRNA-106a Provides Negative Feedback Regulation in Lipopolysaccharide-Induced Inflammation by targeting TLR4.

Authors:  Jing Yang; Yu Chen; Kangfeng Jiang; Yaping Yang; Gan Zhao; Shuai Guo; Ganzhen Deng
Journal:  Int J Biol Sci       Date:  2019-08-22       Impact factor: 6.580

Review 9.  NFAT5-Mediated Signalling Pathways in Viral Infection and Cardiovascular Dysfunction.

Authors:  Guangze Zhao; Sana Aghakeshmiri; Yankuan T Chen; Huifang M Zhang; Fione Yip; Decheng Yang
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

10.  IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b.

Authors:  Ruili Yang; Huaming Huang; Shengjie Cui; Yikun Zhou; Ting Zhang; Yanheng Zhou
Journal:  Cell Death Dis       Date:  2020-07-30       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.